Perceive Pharma develops novel small molecule neuroprotective therapeutics for ophthalmic diseases, including glaucoma.

IntusCare provides predictive analytics and care management solutions for geriatric care, focusing on revenue integrity, population health, and utilization management.

Nema Health provides virtual treatment for PTSD, offering a comprehensive care program including therapists, peer mentors, case managers, and psychiatrists, with plans to expand nationwide and partner with additional insurance plans.

Pleno, Inc. is a clinical and multi-omics diagnostics company focused on revolutionizing biological target detection with its RAPTOR™ multi-omic instrument platform.

Petfolk is a modern veterinary care company that provides in-person and virtual veterinary services through their pet care centers and mobile app, aiming to reshape the veterinary profession by providing best-in-class service and elevating veterinarians through their Partner Program.

SpectraWAVE, Inc. develops advanced medical imaging systems to improve coronary stenting procedures and enhance clinical decision-making in the treatment of coronary artery disease.

Bicara Therapeutics is a clinical-stage biotech company focused on developing BCA101, a novel bifunctional inhibitor targeting EGFR and TGF-β pathways for the treatment of various cancers.

Adela is a healthcare technology company that specializes in blood testing for early cancer detection and minimal residual disease monitoring using a genome-wide methylome enrichment platform.

Actio Biosciences is a biotechnology company that uses its proprietary platform for genetics and precision medicine to develop therapeutics for both rare and common diseases, with a focus on TRPV4 mutations for the treatment of Charcot-Marie-Tooth disease type 2C and other serious bone diseases.